Kai Rejeski

Also affiliated with LMU Klinikum, Ludwig-Maximilians-Universität München

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management”.

Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management

The Lancet Haematology(2024)10.1016/s2352-3026(24)00077-2

N/A

0.705DataRank · unranked

109 citations

Michael D. Jain, Nirali N. Shah, Miguel‐Angel Perales, Marion Subklewe, Kai Rejeski

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0056

N/A

0.557DataRank · unranked

40 citations

Sae Bom Lee, Michael D. Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski +28 more

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Blood Advances(2024)10.1182/bloodadvances.2024014555

N/A

0.406DataRank · unranked

14 citations

Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna +15 more

Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-24-0163

N/A

0.396DataRank · unranked

13 citations

Susan DeWolf, Teng Fei, Sandeep Raj, Gunjan L. Shah, Caleb A. Lareau +18 more

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025017526

N/A

0.267DataRank · unranked

3 citations

Chenyu Lin, David Nemirovsky, Sean Devlin, Kai Rejeski, Kevin J. Curran +43 more

Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALL

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012436

N/A

0.244DataRank · unranked

4 citations

Flavia Gava, Yannis K. Valtis, Toshihisa Satta, Surabhi B Vora, Joseph M. Rocco +9 more

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Blood(2025)10.1182/blood.2025028833

N/A

0DataRank · unranked

34 citations

Jaime Sanz, Teng Fei, Monica Nair, Hamza Hashmi, Abraham Avigdor +32 more

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Molecular Therapy(2025)10.1016/j.ymthe.2025.03.048

N/A

0DataRank · unranked

13 citations

Mohammad Alhomoud, Roni Shouval, Gloria Iacoboni, Edward R. Scheffer Cliff, Doris K. Hansen +6 more

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

Blood Cancer Journal(2025)10.1038/s41408-025-01321-w

N/A

0DataRank · unranked

11 citations

Stephanie Lobaugh, Danny Luan, Marina Gómez-Llobell, P Subramanian, Sean M. Devlin +22 more

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01338-1

N/A

0DataRank · unranked

8 citations

Sandeep Raj, Michael D. Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann +26 more

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

Blood Advances(2025)10.1182/bloodadvances.2025017011

N/A

0DataRank · unranked

7 citations

Richard Aplenc, Susanne H.C. Baumeister, Marco Becilli, Anand Bhagwat, Challice L. Bonifant +30 more

Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma

Bone Marrow Transplantation(2025)10.1038/s41409-025-02519-z

N/A

0DataRank · unranked

5 citations

Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib, Jessica Flynn +22 more

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01273-1

N/A

0DataRank · unranked

4 citations

Sean M. Devlin, Kai Rejeski, Jessica Flynn, Magdalena Corona, Efrat Luttwak +21 more

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

American Journal of Hematology(2023)10.1002/ajh.27056

N/A

0DataRank · unranked

48 citations

Yucai Wang, Omar Albanyan, Javier Muñoz, Pierre Sesques, Gloria Iacoboni +15 more

Patterns and safety of glucocorticosteroid use following CD19 CAR‐T therapy for large B‐cell lymphoma

HemaSphere(2025)10.1002/hem3.70248

N/A

0DataRank · unranked

0 citations

David Nemirovsky, Sean M. Devlin, Alexander P. Boardman, Giulio Cassanello, Magdalena Corona +19 more

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

Nature Medicine(2024)10.1038/s41591-024-03084-6

N/A

0DataRank · unranked

257 citations

Tobias Tix, Roni Shouval, Anat Gafter‐Gvili, Jean-Baptiste Alberge, Edward R. Scheffer Cliff +7 more

Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1798

N/A

0DataRank · unranked

98 citations

Mohammad Alhomoud, Roni Shouval, Edward R. Scheffer Cliff, Miguel‐Angel Perales, David M. Cordas dos Santos +2 more

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.027

N/A

0DataRank · unranked

13 citations

Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna +16 more

Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity

Bone Marrow Transplantation(2024)10.1038/s41409-024-02278-3

N/A

0DataRank · unranked

17 citations

Kai Rejeski, Teng Fei, Aya Albittar, Jennifer J. Huang, Andrew J. Portuguese +6 more

Non-relapse mortality after CAR T-cell therapy: A systematic review and meta-analysis of 7,788 lymphoma and myeloma patients

Research Square(2024)10.21203/rs.3.rs-3907430/v1

N/A

0DataRank · unranked

0 citations

David Cordas dos Santos, Tobias Tix, Roni Shouval, Edward R. Scheffer Cliff, Sebastian Theurich +5 more